Authors

• Rita Chiari (ORCID: https://orcid.org/0000-0002-7649-273X)
• Francesca Toffalorio (ORCID: https://orcid.org/0009-0006-1368-9347)
• Benjamin Besse (ORCID: https://orcid.org/0000-0001-5090-8189)
• Alessandra Bearz (ORCID: https://orcid.org/0000-0003-1020-2338)
• Ross Andrew Soo (ORCID: https://orcid.org/0000-0002-3053-3997)
• Chia‐Chi Lin
• Benjamin Solomon (ORCID: https://orcid.org/0000-0003-3059-5730)
• Antonello Abbattista
• D. Ross Camidge (ORCID: https://orcid.org/0000-0003-3430-3213)
• Sai‐Hong Ignatius Ou (ORCID: https://orcid.org/0000-0002-1764-4975)
• Jessica J. Lin

Institutions

• Université Paris-Sud (FR)
• Peter MacCallum Cancer Centre (AU)
• Institut Gustave Roussy (FR)
• Massachusetts General Hospital (US)
• Azienda Ospedaliera di Perugia (IT)
• University of California, Irvine Medical Center (US)
• National University Cancer Institute, Singapore (SG)
• Centro di Riferimento Oncologico (IT)
• National Taiwan University Hospital (TW)
• University of Colorado Cancer Center (US)
• Pfizer (Italy) (IT)
• National University Health System (SG)
• Istituti di Ricovero e Cura a Carattere Scientifico (IT)
• University of Colorado Denver (US)

Publication Details

Journal

Journal of Thoracic Oncology

Published

2024-11-22

DOI

https://doi.org/10.1016/j.jtho.2024.11.021

Citations

13

Primary Topic

Lung Cancer Treatments and Mutations

Type

article

Field-Weighted Citation Impact

5.45

Funders

• Pfizer